Introduction
Materials and methods
Study design
Ethical considerations
Assessment of abdominal fat by computed tomography
Clinical characteristics and follow-up
Metabolic syndrome
Statistical analysis
Results
Clinical and PD-associated parameters among patients
1 | 2 | 3 | |||||||
---|---|---|---|---|---|---|---|---|---|
Non-MetS, n = 73 | MetS, n = 65 | DM, n = 45 | |||||||
Mean | ± | SD | Mean | ± | SD | Mean | ± | SD | |
Women | 39 | 40 | 19 | ||||||
CAD | 6 | 8 | 17* | ||||||
Hypertension | 55 | 58* | 40 | ||||||
RAS blocker | 37 | 34 | 19 | ||||||
Beta blocker | 35 | 49* | 28 | ||||||
Statin | 17 | 24 | 18 | ||||||
Age | 51 | ± | 14 | 53 | ± | 12 | 58 | ± | 11* |
PD vintage (months) | 46 | ± | 45 | 49 | ± | 36 | 22 | ± | 19* |
Body weight (kg) | 57 | ± | 9 | 61 | ± | 12* | 68 | ± | 13* |
Renal KT/V | 0.22 | ± | 0.33 | 0.17 | ± | 0.32 | 0.18 | ± | 0.23 |
Peritoneal KT/V | 1.87 | ± | 0.41 | 1.92 | ± | 0.35 | 1.79 | ± | 0.31 |
4-h D/P Cre | 0.67 | ± | 0.10 | 0.64 | ± | 0.09* | 0.68 | ± | 0.11 |
D4/D0 Glu | 0.37 | ± | 0.07 | 0.40 | ± | 0.06* | 0.39 | ± | 0.07 |
Glucose exposure (kg/year) | 53 | ± | 19 | 56 | ± | 20 | 58 | ± | 22 |
Dialysate glucose load (g/dL) | 1.86 | ± | 0.33 | 1.87 | ± | 0.31 | 2.11 | ± | 0.31 |
nPCR (gm/[kg/day]) | 1.02 | ± | 0.19 | 0.93 | ± | 0.16* | 0.90 | ± | 0.21* |
Albumin (g/mdL) | 3.9 | ± | 0.3 | 4.1 | ± | 0.3* | 4.0 | ± | 0.4 |
Hemoglobin (g/dL) | 10.2 | ± | 1.2 | 10.0 | ± | 1.6 | 10.2 | ± | 1.0 |
Creatinine (mg/dL) | 11.5 | ± | 2.9 | 11.2 | ± | 2.7 | 10.9 | ± | 2.6 |
Glucose (mg/dL) | 92 | ± | 11 | 106 | ± | 24* | 139 | ± | 52* |
Cholesterol (mg/dL) | 197 | ± | 44 | 202 | ± | 48 | 186 | ± | 41 |
Triglyceride (mg/dL) | 116 | ± | 54 | 273 | ± | 208* | 203 | ± | 133* |
HDL (mg/dL) | 48 | ± | 15 | 37 | ± | 7* | 36 | ± | 12* |
LDL (mg/dL) | 100 | ± | 39 | 87 | ± | 42 | 85 | ± | 37* |
AI1 | 0.36 | ± | 0.25 | 0.80 | ± | 0.26* | 0.67 | ± | 0.35* |
AI2 | 3.31 | ± | 1.31 | 4.58 | ± | 1.31* | 4.42 | ± | 1.58* |
CRP (mg/dL) | 0.97 | ± | 2.31 | 1.27 | ± | 2.57a | 1.11 | ± | 1.35a |
Cardiothoracic ratio (%) | 48 | ± | 7 | 50 | ± | 7 | 53 | ± | 6 |
SFA (cm2/[kg/m2]) | 4.8 | ± | 2.4 | 6.1 | ± | 2.0* | 7.3 | ± | 2.8* |
TFA (cm2/[kg/m2]) | 8.0 | ± | 3.6 | 10.7 | ± | 3.4* | 12.1 | ± | 3.8* |
VFA (cm2/[kg/m2]) | 3.2 | ± | 1.8 | 4.6 | ± | 1.9* | 4.9 | ± | 2.0* |
Predictors for VFA, SFA, and TFA
Non-DM, n = 138 | DM, n = 45 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
VFA | SFA | TFA | VFA | SFA | TFA | |||||||
Sex | −0.04 | 0.31 |
*
| 0.17 |
*
| 0.02 | 0.23 | 0.18 | ||||
CAD | 0.06 | 0.01 | 0.04 | 0.25 | 0.02 | 0.15 | ||||||
Hypertension | −0.15 | 0.06 | −0.04 | 0.31 |
*
| 0.06 | 0.20 | |||||
RAS blocker | −0.17 |
*
| −0.17 |
*
| −0.20 |
*
| −0.06 | −0.13 | −0.13 | |||
Beta blocker | 0.15 |
*
| 0.27 |
*
| 0.24 |
*
| 0.08 | −0.12 | −0.04 | |||
Statin | 0.10 | 0.14 | 0.14 | −0.08 | −0.12 | −0.13 | ||||||
Age | 0.40 |
*
| 0.35 |
*
| 0.43 |
*
| 0.50 |
*
| 0.06 | 0.31 |
*
| |
PD vintage | 0.00 | −0.09 | −0.06 | −0.20 | −0.04 | −0.13 | ||||||
Body weight | 0.38 |
*
| 0.15 | 0.29 |
*
| −0.08 | 0.37 |
*
| 0.23 | |||
BMI | 0.44 |
*
| 0.41 |
*
| 0.49 |
*
| 0.02 | 0.54 |
*
| 0.41 |
*
| |
Renal KT/V | 0.07 | 0.15 | 0.13 | 0.14 | 0.05 | 0.10 | ||||||
Peritoneal KT/V | −0.18 |
*
| −0.14 | −0.18 |
*
| −0.12 | 0.10 | 0.02 | ||||
4 hr D/P Cre | −0.05 | −0.04 | −0.05 | −0.02 | 0.19 | 0.13 | ||||||
D4/D0 Glu | 0.15 | 0.10 | 0.14 | −0.03 | −0.15 | −0.13 | ||||||
Glucose exposure | −0.07 | −0.07 | −0.08 | 0.01 | 0.22 | 0.16 | ||||||
Dialysate glucose load | −0.02 | 0.02 | 0.00 | 0.09 | −0.07 | 0.00 | ||||||
nPCR | −0.23 |
*
| −0.27 |
*
| −0.28 |
*
| −0.25 | −0.21 | −0.28 | |||
Albumin | 0.22 |
*
| 0.06 | 0.15 | 0.09 | −0.03 | 0.02 | |||||
Hemoglobin | 0.05 | 0.03 | 0.05 | 0.01 | −0.37 |
*
| −0.26 | |||||
Creatinine | −0.13 | −0.29 |
*
| −0.25 |
*
| −0.35 |
*
| −0.20 | −0.32 |
*
| ||
Glucose | 0.17 |
*
| 0.10 | 0.15 | 0.11 | 0.29 |
*
| 0.27 | ||||
Cholesterol | 0.16 | 0.24 |
*
| 0.23 |
*
| 0.24 | 0.22 | 0.28 | ||||
Triglyceride | 0.27 |
*
| 0.12 | 0.22 |
*
| 0.54 |
*
| 0.34 |
*
| 0.53 |
*
| |
HDL | −0.27 |
*
| 0.01 | −0.14 | −0.26 | −0.22 | −0.30 |
*
| ||||
LDL | −0.02 | 0.06 | 0.03 | −0.11 | 0.09 | 0.01 | ||||||
AI1 | 0.42 |
*
| 0.19 |
*
| 0.34 |
*
| 0.55 |
*
| 0.41 |
*
| 0.59 |
*
|
AI2 | 0.39 |
*
| 0.18 |
*
| 0.32 |
*
| 0.45 |
*
| 0.31 |
*
| 0.46 |
*
|
LnCRP | 0.36 |
*
| 0.16 | 0.29 |
*
| 0.02 | 0.19 | 0.15 | ||||
Cardiothoracic ratio (%) | 0.25 |
*
| 0.32 |
*
| 0.33 |
*
| 0.32 |
*
| 0.23 | 0.33 |
*
|
A. | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
VFA | SFA | TFA | ||||||||||
B | ± | SE |
P
| B | ± | SE |
P
| B | ± | SE |
P
| |
Constant | −7.58 | ± | 1.89 | < 0.001 | −6.86 | ± | 1.77 | < 0.001 | −13.34 | ± | 2.86 | < 0.001 |
Woman | 0.51 | ± | 0.33 | 0.13 | 2.64 | ± | 0.40 | < 0.001 | 2.81 | ± | 0.62 | < 0.001 |
Age (per 10 years) | 0.40 | ± | 0.10 | < 0.001 | 0.43 | ± | 0.12 | < 0.001 | 0.76 | ± | 0.19 | < 0.001 |
BW (per 10 kg) | 0.95 | ± | 0.15 | < 0.001 | 1.26 | ± | 0.18 | < 0.001 | 2.20 | ± | 0.27 | < 0.001 |
Creatinine | −0.17 | ± | 0.05 | < 0.01 | −0.19 | ± | 0.06 | < 0.01 | −0.37 | ± | 0.09 | < 0.001 |
Albumin | 0.95 | ± | 0.37 | < 0.05 | ||||||||
AI2 | 0.30 | ± | 0.09 | < 0.001 | ||||||||
LnCRP | 0.27 | ± | 0.08 | < 0.001 | 0.43 | ± | 0.14 | < 0.01 | ||||
RAS blocker | −0.62 | ± | 0.25 | < 0.05 | −0.92 | ± | 0.47 | 0.05 | ||||
Beta blocker | 1.03 | ± | 0.30 | < 0.001 | 1.35 | ± | 0.45 | < 0.01 | ||||
Cholesterol (per 10 mg/dL) | 0.11 | ± | 0.05 | < 0.05 | ||||||||
D4/D0 Glu (per 0.1) | 0.67 | ± | 0.33 | < 0.05 | ||||||||
R2 | 0.559 | 0.476 | 0.600 | |||||||||
B.
| ||||||||||||
VFA
|
SFA
|
TFA
| ||||||||||
B
|
±
|
SE
|
P
|
B
|
±
|
SE
|
P
|
B
|
±
|
SE
|
P
| |
Constant | −0.29 | ± | 1.30 | 0.83 | −8.10 | ± | 3.56 | < 0.05 | −7.60 | ± | 4.78 | 0.12 |
Woman | −0.26 | ± | 0.47 | 0.59 | 2.75 | ± | 0.73 | < 0.001 | 2.57 | ± | 0.97 | < 0.05 |
Age (per 10 years) | 0.71 | ± | 0.21 | < 0.01 | 0.21 | ± | 0.33 | 0.53 | 0.80 | ± | 0.44 | 0.08 |
Cholesterol (per 10 mg/dL) | 0.07 | ± | 0.02 | < 0.001 | ||||||||
BW (per 10 kg) | 1.28 | ± | 0.31 | < 0.001 | 1.20 | ± | 0.41 | < 0.01 | ||||
AI1 | 2.38 | ± | 1.02 | < 0.05 | 4.93 | ± | 1.37 | < 0.001 | ||||
R2 | 0.445 | 0.464 | 0.491 |
Abdominal fat area in MetS
Effects of MetS on PD patient outcomes
Triglyceride | High density lipoprotein | Hypertension | Body mass index | Glucose | ||||||
---|---|---|---|---|---|---|---|---|---|---|
− | + | − | + | − | + | − | + | − | + | |
69 | 69 | 52 | 86 | 22 | 116 | 113 | 25 | 94 | 44 | |
CRP (mg/dL) | 1.0 ± 2.6 | 1.2 ± 2.3 | 1.0 ± 2.4 | 1.2 ± 2.5* | 2.0 ± 3.7 | 1.0 ± 2.1* | 0.9 ± 2.0 | 2.0 ± 3.7* | 1.0 ± 2.1 | 1.4 ± 3.0* |
VFA (cm2/[kg/m2]) | 3.1 ± 1.8 | 4.6 ± 1.9* | 3.2 ± 1.8 | 4.2 ± 2.0* | 4.6 ± 2.0 | 3.7 ± 2.0 | 3.5 ± 1.8 | 5.4 ± 1.9* | 3.6 ± 2.1 | 4.4 ± 1.8* |
Cardiothoracic ratio (%) | 48 ± 6 | 49 ± 7 | 48 ± 6 | 49 ± 7 | 47 ± 7 | 49 ± 7 | 48 ± 7 | 50 ± 5 | 48 ± 7 | 50 ± 7 |
Albumin (g/dL) | 3.9 ± 0.3 | 4.1 ± 0.3* | 3.9 ± 0.4 | 4.1 ± 0.3* | 4.0 ± 0.3 | 4.0 ± 0.4 | 4.0 ± 0.3 | 4.1 ± 0.4 | 4.0 ± 0.3 | 4.1 ± 0.4 |
Renal KT/V | 0.21 ± 0.32 | 0.19 ± 0.32 | 0.30 ± 0.37 | 0.14 ± 0.28* | 0.10 ± 0.16 | 0.22 ± 0.34* | 0.17 ± 0.29 | 0.32 ± 0.44* | 0.20 ± 0.32 | 0.21 ± 0.32 |
Glucose load (g/dL) | 1.88 ± 0.33 | 1.86 ± 0.31 | 1.80 ± 0.29 | 1.91 ± 0.33 | 1.82 ± 0.31 | 1.88 ± 0.32 | 1.86 ± 0.32 | 1.89 ± 0.34 | 1.87 ± 0.33 | 1.85 ± 0.29 |
Glucose exposure (kg/year) | 56 ± 20 | 53 ± 19 | 49 ± 19 | 58 ± 20* | 53 ± 12 | 55 ± 21 | 54 ± 20 | 57 ± 21 | 55 ± 20 | 53 ± 19 |
CAD History | 7 | 7 | 3 | 11 | 3 | 11 | 12 | 2 | 8 | 6 |
CVD Event | 5 | 5 | 3 | 7 | 1 | 9 | 8 | 2 | 7 | 3 |